2019 annual financial data
Taysha Gene Therapies 2019 Operating cash flow
Direct answer
Operating cash flow was 135,000 USD.
Operating income was -1,115,000 USD and net income was -1,115,000 USD.
Operating cash flow was 135,000 USD.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -1,115,000 USD
- Net income
- -1,115,000 USD
- Operating cash flow
- 135,000 USD